Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma

Clinical Cancer Research

Volumn 21, Issue 7, 2015, Pages 1741-1751

  O'Leary, Brianne R ^a   Fath, Melissa A ^a   Bellizzi, Andrew M ^a   Hrabe, Jennifer E ^a   Button, Anna M ^b   Allen, Bryan G ^a   Case, Adam J ^a   Altekruse, Sean ^c   Wagner, Brett A ^a   Buettner, Garry R ^a   Lynch, Charles F ^b   Hernandez, Brenda Y ^d   Cozen, Wendy ^e   Beardsley, Robert A ^f   Keene, Jeffery ^f   Henry, Michael D ^b   Domann, Frederick E ^a   Spitz, Douglas R ^a   Mezhir, James J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Galera Therapeutics Inc Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRACELLULAR SUPEROXIDE DISMUTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SUPEROXIDE; SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SOD3 PROTEIN, HUMAN;

ADENOCARCINOMA CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BXPC3 CELL LINE; CANCER GROWTH; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOSS; GENE OVEREXPRESSION; HPNE CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MIAPACA2 CELL LINE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PANCREAS ADENOCARCINOMA; PERITONEUM METASTASIS; PHENOTYPE; PRIORITY JOURNAL; SOD3 GENE; TISSUE MICROARRAY; TUMOR INVASION; TUMOR XENOGRAFT; ANIMAL; BIOSYNTHESIS; CANCER REGISTRY; IMMUNOHISTOCHEMISTRY; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PHENOTYPE; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; SEER PROGRAM; SUPEROXIDE DISMUTASE; TISSUE ARRAY ANALYSIS;

EID: 84927660940     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-1959     Document Type: Article

References (41)

1. Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci U S A 1995;92:6264-8.
2. Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficientmice. Circ Res 2003;93:622-9.
3. Marklund SL. Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 1984;74:1398-403.
4. Ridnour LA, Oberley TD, Oberley LW. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal 2004;6:501-12.
5. Oberley LW, Oberley TD, Buettner GR. Cell division in normal and transformed cells: the possible role of superoxide and hydrogen peroxide. Med Hypotheses 1981;7:21-42.
6. Oberley LW, Oberley TD, Buettner GR. Cell differentiation, aging and cancer: the possible roles of superoxide and superoxide dismutases. Med Hypotheses 1980;6:249-68.
7. Oberley LW, Oberley TD. Role of antioxidant enzymes in cell immortalization and transformation. Mol Cell Biochem 1988;84:147-53.
8. Chaiswing L, Zhong W, Cullen JJ, Oberley LW, Oberley TD. Extracellular redox state regulates features associated with prostate cancer cell invasion. Cancer Res 2008;68:5820-6.
9. Chaiswing L, Zhong W, Liang Y, Jones DP, Oberley TD. Regulation of prostate cancer cell invasion by modulation of extra- and intracellular redox balance. Free Radic Biol Med 2012;52:452-61.
10. Lewis A, Du J, Liu J, Ritchie JM, Oberley LW, Cullen JJ. Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth. Clin Exp Metastasis 2005;22:523-32.
11. Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, Goswami PC. Redox control of the cell cycle in health and disease. Antioxid Redox Signal 2009;11:2985-3011.
12. Menon SG, Coleman MC, Walsh SA, Spitz DR, Goswami PC. Differential susceptibility of nonmalignant human breast epithelial cells and breast cancer cells to thiol antioxidant-induced G(1)-delay. Antioxid Redox Signal 2005;7:711-8.
13. Jorgenson TC, Zhong W, Oberley TD. Redox imbalance and biochemical changes in cancer. Cancer Res 2013;73:6118-23.
14. Oberley LW, Buettner GR. Role of superoxide dismutase in cancer: a review. Cancer Res 1979;39:1141-9.
15. Gius D, Spitz DR. Redox signaling in cancer biology. Antioxid Redox Signal 2006;8:1249-52.
16. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003;31(Pt 6):1441-4.
17. Teoh ML, Sun W, Smith BJ, Oberley LW, Cullen JJ. Modulation of reactive oxygen species in pancreatic cancer. Clin Cancer Res 2007;13:7441-50.
18. Teoh-Fitzgerald ML, Fitzgerald MP, Jensen TJ, Futscher BW, Domann FE. Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis. Mol Cancer Res 2012;10:40-51.
19. Sibenaller ZA, Welsh JL, Du C, Witmer JR, Schrock HE, Du J, et al. Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1alpha in pancreatic cancer. Free Radic Biol Med 2014;69:357-66.
20. Teoh-Fitzgerald ML, Fitzgerald MP, Zhong W, Askeland RW, Domann FE. Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis. Oncogene 2014;33:358-68.
21. Teoh ML, Fitzgerald MP, Oberley LW, Domann FE. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res 2009;69:6355-63.
22. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004;6:1-6.
23. Takikita M, Altekruse S, Lynch CF, Goodman MT, Hernandez BY, Green M, et al. Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray. Cancer Res 2009;69:2950-5.
24. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003;92:461-8.
25. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, et al. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 2003;63:1297-303.
26. Case AJ, Mezhir JJ, O'Leary BR, Hrabe JE, Domann FE. Rational design of a secreted enzymatically inactive mutant of extracellular superoxide dismutase. Redox Rep 2012;17:239-45.
27. Yao H, Arunachalam G, Hwang JW, Chung S, Sundar IK, Kinnula VL, et al. Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc Natl Acad Sci U S A 2010;107:15571-6.
28. Finkelstein E, Rosen GM, Rauckman EJ. Spin trapping - kinetics of the reaction of superoxide and hydroxyl radicals with nitrones. J AmChem Soc 1980;102:4994-9.
29. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 1982;79:7634-8.
30. Goldstein S, Fridovich I, Czapski G. Kinetic properties of Cu,Zn-superoxide dismutase as a function of metal content - order restored. Free Radic Biol Med 2006;41:937-41.
31. Chaiswing L, Zhong W, Oberley TD. Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression. Free Radic Biol Med 2014;67:342-52.
32. Svensk AM, Soini Y, Paakko P, Hiravikoski P, Kinnula VL. Differential expression of superoxide dismutases in lung cancer. Am J Clin Pathol 2004;122:395-404.
33. Tsikas D, Duncan MW. Mass spectrometry and 3-nitrotyrosine: strategies, controversies, and our current perspective. Mass Spectrom Rev 2014;33:237-76.
34. Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta 2013;1830:4117-29.
35. Obal D, Dai S, Keith R, Dimova N, Kingery J, Zheng YT, et al. Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Basic Res Cardiol 2012;107:305.
36. Coleman MC, Olivier AK, Jacobus JA, Mapuskar KA, Mao G, Martin SM, et al. Superoxide mediates acute liver injury in irradiated mice lacking sirtuin 3. Antioxid Redox Signal 2014;20:1423-35.
37. Wheeler MD, Smutney OM, Samulski RJ. Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice. Mol Cancer Res 2003;1:871-81.
38. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013;369:1691-703.
39. Vickers SM, MacMillan-Crow LA, Green M, Ellis C, Thompson JA. Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. Arch Surg 1999;134:245-51.
40. Blackburn RV, Spitz DR, Liu X, Galoforo SS, Sim JE, Ridnour LA, et al. Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic Biol Med 1999;26:419-30.
41. Takenaga M, Igarashi R, Ochiai A, Mizushima Y. Effect of lecithinized superoxide dismutase (PC-SOD) on experimental pulmonary metastasis in mice. Free Radic Biol Med 1999;26:1117-25.